Saudi Pharmaceutical Industries and Medical Appliances
Market Cap
ر.س7.1b
Last Updated
2021/07/29 16:14 UTC
Data Sources
Company Financials +
Executive Summary
Saudi Pharmaceutical Industries and Medical Appliances develops, manufactures, and markets medicinal products and pharmaceutical formulations in the Kingdom of Saudi Arabia, Egypt, the Middle East, Morocco, and Algeria. More Details
Rewards
Risk Analysis
Snowflake Analysis
Average dividend payer with mediocre balance sheet.
Share Price & News
How has Saudi Pharmaceutical Industries and Medical Appliances's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 2070 is more volatile than 75% of SA stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 2070's weekly volatility (5%) has been stable over the past year, but is still higher than 75% of SA stocks.
Market Performance
7 Day Return
2.1%
2070
-3.2%
SA Pharmaceuticals
0.3%
SA Market
1 Year Return
89.8%
2070
-4.8%
SA Pharmaceuticals
14.8%
SA Market
Return vs Industry: 2070 exceeded the SA Pharmaceuticals industry which returned -6.3% over the past year.
Return vs Market: 2070 exceeded the SA Market which returned 14.4% over the past year.
Shareholder returns
| 2070 | Industry | Market | |
|---|---|---|---|
| 7 Day | 2.1% | -3.2% | 0.3% |
| 30 Day | 2.9% | -7.8% | -1.1% |
| 90 Day | 33.0% | -2.9% | 0.02% |
| 1 Year | 93.9%89.8% | -3.7%-4.8% | 19.2%14.8% |
| 3 Year | 106.0%87.7% | 29.0%22.6% | 42.2%29.2% |
| 5 Year | 95.3%67.6% | 40.2%29.5% | 104.7%74.0% |
Long-Term Price Volatility Vs. Market
How volatile is Saudi Pharmaceutical Industries and Medical Appliances's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall St
Can You Imagine How Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders Feel About The 87% Share Price Increase?Valuation
Is Saudi Pharmaceutical Industries and Medical Appliances undervalued compared to its fair value and its price relative to the market?
65.67x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 2070 (SAR59.5) is trading above our estimate of fair value (SAR7.43)
Significantly Below Fair Value: 2070 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 2070 is poor value based on its PE Ratio (65.7x) compared to the Asian Pharmaceuticals industry average (24.1x).
PE vs Market: 2070 is poor value based on its PE Ratio (65.7x) compared to the SA market (33.5x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 2070's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 2070 is overvalued based on its PB Ratio (3.7x) compared to the XA Pharmaceuticals industry average (2.4x).
Future Growth
How is Saudi Pharmaceutical Industries and Medical Appliances forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
14.2%
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 2070's forecast earnings growth is above the savings rate (8.8%).
Earnings vs Market: Insufficient data to determine if 2070's earnings are forecast to grow faster than the SA market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2070's revenue (14.2% per year) is forecast to grow faster than the SA market (3.4% per year).
High Growth Revenue: 2070's revenue (14.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2070's Return on Equity is forecast to be low in 3 years time (11.8%).
Past Performance
How has Saudi Pharmaceutical Industries and Medical Appliances performed over the past 5 years?
-50.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 2070 has high quality earnings.
Growing Profit Margin: 2070 became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: 2070's earnings have declined by 50.8% per year over the past 5 years.
Accelerating Growth: 2070 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 2070 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (21%).
Return on Equity
High ROE: 2070's Return on Equity (4.5%) is considered low.
Financial Health
How is Saudi Pharmaceutical Industries and Medical Appliances's financial position?
Financial Position Analysis
Short Term Liabilities: 2070's short term assets (SAR2.7B) exceed its short term liabilities (SAR1.6B).
Long Term Liabilities: 2070's short term assets (SAR2.7B) exceed its long term liabilities (SAR1.0B).
Debt to Equity History and Analysis
Debt Level: 2070's debt to equity ratio (62.8%) is considered high.
Reducing Debt: 2070's debt to equity ratio has increased from 19.2% to 62.8% over the past 5 years.
Debt Coverage: 2070's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 2070's interest payments on its debt are well covered by EBIT (3.5x coverage).
Balance Sheet
Dividend
What is Saudi Pharmaceutical Industries and Medical Appliances's current dividend yield, its reliability and sustainability?
1.68%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 2070's dividend (1.68%) is higher than the bottom 25% of dividend payers in the SA market (1.46%).
High Dividend: 2070's dividend (1.68%) is low compared to the top 25% of dividend payers in the SA market (4.26%).
Stability and Growth of Payments
Stable Dividend: 2070's dividends per share have been stable in the past 10 years.
Growing Dividend: 2070's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (110.4%), 2070's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: 2070's dividends in 3 years are forecast to be covered by earnings (50.8% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
0.9yrs
Average management tenure
CEO
Khalid Saleh Al-Khattaf
no data
Tenure
H.E. Khalid Saleh Fahd Al-Khattaf serves as the Chief Executive Officer at Saudi Pharmaceutical Industries and Medical Appliances Corporation. He served as Senior Vice President of Finance and Chief Financ...
Leadership Team
Experienced Management: 2070's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Board Members
Experienced Board: 2070's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Saudi Pharmaceutical Industries and Medical Appliances Corporation's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Saudi Pharmaceutical Industries and Medical Appliances Corporation
- Ticker: 2070
- Exchange: SASE
- Founded: 1986
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: ر.س7.140b
- Shares outstanding: 120.00m
- Website: https://www.spimaco.com.sa
Location
- Saudi Pharmaceutical Industries and Medical Appliances Corporation
- King Abdul Aziz Road
- Qassim Industrial City
- Buraydah
- Saudi Arabia
Listings
Biography
Saudi Pharmaceutical Industries and Medical Appliances develops, manufactures, and markets medicinal products and pharmaceutical formulations in the Kingdom of Saudi Arabia, Egypt, the Middle East, Morocco...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/07/29 16:14 |
| End of Day Share Price | 2021/07/29 00:00 |
| Earnings | 2021/03/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.